Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population
Authors:
- Yaping XuYXYaping Xu
- Qinghua DengQDQinghua Deng
- Xinmin YuXYXinmin Yu
- 1 August 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 65 (2) , 198-203
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brainLung Cancer, 2007
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2005
- Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and manXenobiotica, 2004
- Predicting Sensitivity of Non-Small-Cell Lung Cancer to Gefitinib: Is There a Role for P-Akt?JNCI: Journal of the National Cancer Institute, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Identification of prognostic factors in patients with brain metastases: a review of 1292 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Sample size considerations for non-randomized comparative studiesJournal of Chronic Diseases, 1980
- The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1980